Instil Bio Inc
NASDAQ:TIL
Cash Flow Statement
Cash Flow Statement
Instil Bio Inc
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||
| Net Income |
(38)
|
(57)
|
(83)
|
(119)
|
(157)
|
(188)
|
(211)
|
(225)
|
(223)
|
(226)
|
(186)
|
(197)
|
(156)
|
(123)
|
(120)
|
(75)
|
(74)
|
(78)
|
(85)
|
(75)
|
|
| Depreciation & Amortization |
0
|
1
|
1
|
2
|
3
|
3
|
4
|
5
|
6
|
7
|
7
|
6
|
5
|
4
|
4
|
4
|
4
|
3
|
2
|
1
|
|
| Stock-Based Compensation |
2
|
4
|
9
|
18
|
26
|
31
|
33
|
33
|
30
|
27
|
24
|
20
|
18
|
18
|
18
|
17
|
17
|
16
|
14
|
12
|
|
| Other Non-Cash Items |
6
|
9
|
9
|
19
|
28
|
32
|
36
|
36
|
47
|
63
|
57
|
99
|
78
|
61
|
61
|
22
|
27
|
40
|
48
|
38
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
3
|
4
|
5
|
7
|
7
|
7
|
7
|
8
|
7
|
7
|
6
|
|
| Change in Working Capital |
1
|
2
|
(2)
|
2
|
4
|
(7)
|
(3)
|
(2)
|
(10)
|
(4)
|
(10)
|
(14)
|
(9)
|
(3)
|
1
|
(10)
|
(13)
|
(11)
|
(15)
|
(5)
|
|
| Cash from Operating Activities |
(30)
N/A
|
(45)
-52%
|
(74)
-64%
|
(96)
-30%
|
(122)
-27%
|
(159)
-31%
|
(175)
-9%
|
(186)
-7%
|
(180)
+3%
|
(160)
+11%
|
(132)
+17%
|
(106)
+20%
|
(82)
+22%
|
(61)
+25%
|
(53)
+14%
|
(59)
-11%
|
(56)
+5%
|
(46)
+18%
|
(50)
-8%
|
(40)
+19%
|
|
| Investing Cash Flow | |||||||||||||||||||||
| Capital Expenditures |
(51)
|
(59)
|
(67)
|
(85)
|
(58)
|
(69)
|
(87)
|
(90)
|
(85)
|
(73)
|
(54)
|
(34)
|
(21)
|
(12)
|
(5)
|
(10)
|
(10)
|
0
|
0
|
(10)
|
|
| Other Items |
(0)
|
0
|
0
|
(495)
|
(417)
|
(318)
|
(314)
|
232
|
199
|
124
|
137
|
94
|
62
|
48
|
42
|
65
|
64
|
64
|
52
|
41
|
|
| Cash from Investing Activities |
(51)
N/A
|
(59)
-15%
|
(67)
-14%
|
(580)
-763%
|
(474)
+18%
|
(387)
+18%
|
(400)
-3%
|
142
N/A
|
115
-19%
|
51
-55%
|
83
+62%
|
60
-28%
|
41
-31%
|
36
-13%
|
37
+4%
|
55
+47%
|
54
-2%
|
54
+1%
|
42
-22%
|
31
-27%
|
|
| Financing Cash Flow | |||||||||||||||||||||
| Net Issuance of Common Stock |
313
|
708
|
526
|
526
|
393
|
(1)
|
1
|
1
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
7
|
8
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
0
|
50
|
65
|
70
|
75
|
29
|
14
|
8
|
4
|
(1)
|
0
|
1
|
1
|
1
|
1
|
|
| Other |
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
313
N/A
|
708
+126%
|
526
-26%
|
526
N/A
|
393
-25%
|
(1)
N/A
|
51
N/A
|
66
+28%
|
72
+9%
|
76
+6%
|
30
-61%
|
14
-52%
|
8
-43%
|
4
-55%
|
(1)
N/A
|
0
N/A
|
2
+990%
|
2
+13%
|
9
+336%
|
9
+3%
|
|
| Change in Cash | |||||||||||||||||||||
| Effect of Foreign Exchange Rates |
1
|
0
|
0
|
(0)
|
(0)
|
0
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
|
| Net Change in Cash |
233
N/A
|
604
+159%
|
385
-36%
|
(150)
N/A
|
(204)
-36%
|
(548)
-169%
|
(524)
+4%
|
21
N/A
|
6
-73%
|
(34)
N/A
|
(20)
+41%
|
(31)
-57%
|
(33)
-5%
|
(22)
+33%
|
(16)
+26%
|
(3)
+79%
|
(0)
+98%
|
10
N/A
|
1
-88%
|
(1)
N/A
|
|
| Free Cash Flow | |||||||||||||||||||||
| Free Cash Flow |
(80)
N/A
|
(104)
-29%
|
(141)
-36%
|
(181)
-28%
|
(180)
+0%
|
(228)
-27%
|
(261)
-14%
|
(276)
-6%
|
(265)
+4%
|
(233)
+12%
|
(186)
+20%
|
(139)
+25%
|
(103)
+26%
|
(74)
+28%
|
(58)
+21%
|
(69)
-18%
|
(66)
+4%
|
(46)
+30%
|
(50)
-8%
|
(50)
-1%
|
|